AETHLON MEDICAL, INC. Net Income (Loss) Available to Common Stockholders, Diluted
AETHLON MEDICAL, INC. (AEMD) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$3.81 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2022-11-14
- AETHLON MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2022-09-30 was -$3.81M.
- AETHLON MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2021-12-31 was -$2.53M.
- AETHLON MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2021-09-30 was -$2.01M.
- AETHLON MEDICAL, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2020-12-31 was -$2.44M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|
| 2022-09-30 | -$3.81M 10-Q · filed 2022-11-14 | -$6.72M 10-Q · filed 2022-11-14 | |
| 2021-12-31 | -$2.53M 10-Q · filed 2022-02-14 | -$4.53M derived: sum of 2 quarters · filed 2022-11-14 | -$6.63M 10-Q · filed 2022-02-14 |
| 2021-09-30 | -$2.01M 10-Q · filed 2022-11-14 | -$4.11M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | -$2.44M 10-Q · filed 2022-02-14 | -$5.62M 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |